DEUTSCHE BANK AG\ - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 459 filers reported holding REPLIGEN CORP in Q1 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$17,163,699
+9.1%
107,941
-2.9%
0.01%
+37.5%
Q2 2023$15,731,484
+36.1%
111,208
+62.0%
0.01%
+33.3%
Q1 2023$11,559,597
-10.1%
68,660
-9.6%
0.01%
-14.3%
Q4 2022$12,858,587
+116.0%
75,947
+138.7%
0.01%
+75.0%
Q3 2022$5,954,000
-28.9%
31,823
-38.3%
0.00%
-20.0%
Q2 2022$8,371,000
-38.2%
51,545
-28.4%
0.01%
-16.7%
Q1 2022$13,546,000
+103.7%
72,025
+186.8%
0.01%
+100.0%
Q4 2021$6,651,000
-22.5%
25,113
-15.4%
0.00%
-25.0%
Q3 2021$8,577,000
+5.0%
29,676
-27.5%
0.00%0.0%
Q2 2021$8,171,000
-61.0%
40,934
-62.0%
0.00%
-63.6%
Q1 2021$20,934,000
+269.7%
107,672
+264.3%
0.01%
+266.7%
Q4 2020$5,663,000
+22.8%
29,554
-5.5%
0.00%0.0%
Q3 2020$4,613,000
-68.0%
31,261
-73.2%
0.00%
-72.7%
Q2 2020$14,434,000
+51.8%
116,773
+18.6%
0.01%
+37.5%
Q1 2020$9,506,000
-5.8%
98,474
-9.7%
0.01%
+14.3%
Q4 2019$10,086,000
-10.8%
109,053
-26.1%
0.01%
-12.5%
Q3 2019$11,313,000
+10.3%
147,536
+23.6%
0.01%
+33.3%
Q2 2019$10,255,000
-15.7%
119,354
-42.1%
0.01%
-14.3%
Q1 2019$12,170,000
+17.2%
206,015
+4.6%
0.01%0.0%
Q4 2018$10,382,000
-36.4%
196,880
-33.1%
0.01%
+40.0%
Q3 2018$16,312,000
+57.0%
294,146
+33.2%
0.01%
+66.7%
Q2 2018$10,387,000
+66.9%
220,850
+28.3%
0.00%0.0%
Q1 2018$6,224,000
+103.4%
172,090
+103.8%
0.00%
+50.0%
Q4 2017$3,060,000
+72.5%
84,430
+82.1%
0.00%
+100.0%
Q3 2017$1,774,000
-26.1%
46,361
-20.0%
0.00%
-50.0%
Q2 2017$2,399,000
+721.6%
57,936
+596.3%
0.00%
Q1 2017$292,000
-60.5%
8,321
-65.4%
0.00%
-100.0%
Q4 2016$740,000
-56.9%
24,042
-57.8%
0.00%0.0%
Q3 2016$1,718,000
-54.2%
56,961
-58.4%
0.00%
-66.7%
Q2 2016$3,748,000
+53.4%
137,057
+50.4%
0.00%
+50.0%
Q1 2016$2,443,000
-15.6%
91,130
-10.9%
0.00%0.0%
Q4 2015$2,893,000
-32.9%
102,328
-33.9%
0.00%
-33.3%
Q3 2015$4,310,000
-6.7%
154,800
+38.3%
0.00%0.0%
Q2 2015$4,618,000
+47.1%
111,933
+8.2%
0.00%
+50.0%
Q1 2015$3,140,000
+97.0%
103,468
+28.4%
0.00%
+100.0%
Q4 2014$1,594,000
-37.2%
80,595
-36.8%
0.00%
-50.0%
Q3 2014$2,538,000
+36.2%
127,558
+55.9%
0.00%
+100.0%
Q2 2014$1,863,000
+61.0%
81,799
-9.1%
0.00%0.0%
Q1 2014$1,157,000
+164.8%
90,031
+180.6%
0.00%
Q4 2013$437,000
-17.4%
32,088
-34.2%
0.00%
Q3 2013$529,00048,7380.00%
Other shareholders
REPLIGEN CORP shareholders Q1 2021
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders